Orchestra BioMed Holdings, Inc. Tax Withholding Paid on Stock Awards
Orchestra BioMed Holdings, Inc. (OBIO) reported Tax Withholding Paid on Stock Awards of $616.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsRelatedToTaxWithholdingForShareBasedCompensation · last filed 2026-08-10
- Orchestra BioMed Holdings, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-06-30 was $262.00K, a 38.79% decline year-over-year.
- Orchestra BioMed Holdings, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2026-03-31 was $354.00K, a 8.53% decline year-over-year.
- Orchestra BioMed Holdings, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-12-31 was $468.00K.
- Orchestra BioMed Holdings, Inc. payment, tax withholding, share-based payment arrangement for the quarter ending 2025-09-30 was $269.00K.
- Orchestra BioMed Holdings, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2025 was $1.55M, a 182.18% increase from fiscal 2024.
- Orchestra BioMed Holdings, Inc. payment, tax withholding, share-based payment arrangement for fiscal 2024 was $550.00K.
| Period end | Payment, Tax Withholding, Share-based Payment Arrangement 3 month | Payment, Tax Withholding, Share-based Payment Arrangement 6 month | Payment, Tax Withholding, Share-based Payment Arrangement 9 month | Payment, Tax Withholding, Share-based Payment Arrangement 12 month |
|---|---|---|---|---|
| 2026-06-30 | $262.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $616.00K 10-Q · filed 2026-08-10 | $1.08M derived: sum of 3 quarters · filed 2026-08-10 | $1.35M derived: sum of 4 quarters · filed 2026-08-10 |
| 2026-03-31 | $354.00K 10-Q · filed 2026-05-12 | $822.00K derived: sum of 2 quarters · filed 2026-05-12 | $1.09M derived: sum of 3 quarters · filed 2026-05-12 | $1.52M derived: sum of 4 quarters · filed 2026-08-10 |
| 2025-12-31 | $468.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-12 | $737.00K derived: sum of 2 quarters · filed 2026-03-12 | $1.17M derived: sum of 3 quarters · filed 2026-08-10 | $1.55M 10-K · filed 2026-03-12 |
| 2025-09-30 | $269.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | $697.00K derived: sum of 2 quarters · filed 2026-08-10 | $1.08M 10-Q · filed 2025-11-10 | |
| 2025-06-30 | $428.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-10 | $815.00K 10-Q · filed 2026-08-10 | ||
| 2025-03-31 | $387.00K 10-Q · filed 2026-05-12 | |||
| 2024-12-31 | $550.00K 10-K · filed 2026-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |